There were more patients with a BMI of ≥ 25 kg/m 2 in the group with below therapeutic drug levels compared to those with therapeutic levels, with a trend towards significance.
← all excerpts
High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis.
1
—
—